Literature DB >> 30883244

Factors Associated with Black Cancer Patients' Ability to Obtain Their Opioid Prescriptions at the Pharmacy.

Kevin Jefferson1, Tammie Quest2, Katherine A Yeager3.   

Abstract

Background: Black cancer patients experience pain. Barriers to opioid medications for pain may include geographic factors. This study examines neighborhood factors associated with difficulties receiving prescription opioids from pharmacies for black cancer patients. Design: A secondary data analysis of a study on opioid adherence was used to examine neighborhood-level and individual factors related to difficulties filling prescriptions for opioids. Setting/Subjects: Patients being treated for cancer pain with opioids (n = 104) were recruited. All self-identified as black, were 21 years or older, had cancer diagnoses, and had been prescribed extended release opioids. Measurements: A seven-item survey to identify problems filling opioids was completed by 98 participants along with a nine-item scale to assess perceived neighborhood characteristics. Scales of neighborhood amenities and neglect were created from the perceived neighborhood characteristics scale using principal components analysis. The 2009-2013 American Community Survey data were used to estimate the census tract percentage of non-Hispanic black residents, residents ≥25 years of age without a high school degree or equivalent, and households earning below the federal poverty level within the past 12 months.
Results: Nearly 51% reported problems getting their opioids filled: 28% had to wait days and 24% had to return to the pharmacy multiple times. The main theme identified in analysis of an open-ended question was pharmacies not stocking medication. Neighborhood locations that rated higher on the amenities scale were protective for pharmacies sufficiently stocking opioids. Conclusions: Additional research on pharmacies sufficiently stocking opioid pain and neighborhood perceptions is warranted.

Entities:  

Keywords:  black/African American; cancer; neighborhood factors; opioids; pain; pharmacies

Year:  2019        PMID: 30883244      PMCID: PMC6735324          DOI: 10.1089/jpm.2018.0536

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  14 in total

1.  Differences in prescription opioid analgesic availability: comparing minority and white pharmacies across Michigan.

Authors:  Carmen R Green; S Khady Ndao-Brumblay; Brady West; Tamika Washington
Journal:  J Pain       Date:  2005-10       Impact factor: 5.820

Review 2.  Race, ethnicity, and pain among the U.S. adult population.

Authors:  Vickie L Shavers; Alexis Bakos; Vanessa B Sheppard
Journal:  J Health Care Poor Underserved       Date:  2010-02

3.  Adherence to Analgesics for Cancer Pain: A Comparative Study of African Americans and Whites Using an Electronic Monitoring Device.

Authors:  Salimah H Meghani; Aleda M L Thompson; Jesse Chittams; Deborah W Bruner; Barbara Riegel
Journal:  J Pain       Date:  2015-06-14       Impact factor: 5.820

4.  Assessment of pain and analgesic use in African American cancer patients: factors related to adherence to analgesics.

Authors:  Young O Rhee; Eugenia Kim; Bryant Kim
Journal:  J Immigr Minor Health       Date:  2012-12

5.  "We don't carry that"--failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics.

Authors:  R S Morrison; S Wallenstein; D K Natale; R S Senzel; L L Huang
Journal:  N Engl J Med       Date:  2000-04-06       Impact factor: 91.245

Review 6.  Prevalence of pain in patients with cancer: a systematic review of the past 40 years.

Authors:  M H J van den Beuken-van Everdingen; J M de Rijke; A G Kessels; H C Schouten; M van Kleef; J Patijn
Journal:  Ann Oncol       Date:  2007-03-12       Impact factor: 32.976

Review 7.  The unequal burden of pain: confronting racial and ethnic disparities in pain.

Authors:  Carmen R Green; Karen O Anderson; Tamara A Baker; Lisa C Campbell; Sheila Decker; Roger B Fillingim; Donna A Kalauokalani; Donna A Kaloukalani; Kathyrn E Lasch; Cynthia Myers; Raymond C Tait; Knox H Todd; April H Vallerand
Journal:  Pain Med       Date:  2003-09       Impact factor: 3.750

8.  Population-based survey of pain in the United States: differences among white, African American, and Hispanic subjects.

Authors:  Russell K Portenoy; Carlos Ugarte; Ivonne Fuller; Gregory Haas
Journal:  J Pain       Date:  2004-08       Impact factor: 5.820

9.  Pain characteristics and management of inpatients admitted to a comprehensive cancer centre: a cross-sectional study.

Authors:  G P Kurita; U B Tange; H Farholt; N M Sonne; A S Strömgren; L Ankersen; L Kristensen; L Bendixen; M Grønvold; M A Petersen; M Nordly; L Christrup; C Niemann; P Sjøgren
Journal:  Acta Anaesthesiol Scand       Date:  2013-01-22       Impact factor: 2.105

Review 10.  Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis.

Authors:  Marieke H J van den Beuken-van Everdingen; Laura M J Hochstenbach; Elbert A J Joosten; Vivianne C G Tjan-Heijnen; Daisy J A Janssen
Journal:  J Pain Symptom Manage       Date:  2016-04-23       Impact factor: 3.612

View more
  3 in total

1.  When treatment algorithms fail: A response to the development of a nomogram to determine the frequency of elevated risk for non-medical opioid use in cancer patients.

Authors:  Katie Fitzgerald Jones; Zachary Sager; Richard E Leiter; Justin J Sanders
Journal:  Palliat Support Care       Date:  2021-10

2.  Cancer Patients' Perceived Difficulties Filling Opioid Prescriptions After Receiving Outpatient Supportive Care.

Authors:  Jessica H Brown; Hilda P Torres; Rama D Maddi; Janet L Williams; Seyedeh S Dibaj; Diane Liu; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2020-06-20       Impact factor: 3.612

Review 3.  Neighborhood Characteristics and Cancer Survivorship: An Overview of the Current Literature on Neighborhood Landscapes and Cancer Care.

Authors:  Sima Namin; Yuhong Zhou; Joan Neuner; Kirsten Beyer
Journal:  Int J Environ Res Public Health       Date:  2021-07-05       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.